Related Experiment Videos
Two patients with novel BCR/ABL fusion transcripts (e8/a2 and e13/a2) resulting from translocation breakpoints within
1Department of Haematology, Singapore General Hospital, Singapore. ghehgf@sgh.gov.sg
British Journal of Haematology
|May 8, 1999
Summary
Novel BCR-ABL mRNA fusions were found in two leukemia patients. These findings indicate that BCR-ABL translocation breakpoints can occur within coding exons, offering new insights into leukemia development.
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- Philadelphia chromosome-positive leukemia is characterized by the BCR-ABL fusion gene.
- Standard RT-PCR methods detect common BCR-ABL fusion transcripts.
Observation:
- Two patients with Philadelphia chromosome-positive leukemia exhibited novel BCR-ABL mRNA fusions identified via RT-PCR.
- Sequencing revealed specific in-frame fusions: BCR exon e8 to ABL exon a2, and BCR exon e13 to ABL exon a2.
Findings:
- The identified breakpoints within BCR exons e8 and e13 did not align with consensus splice sites.
- Genomic DNA bubble PCR confirmed translocation breakpoints at these non-consensus sites in one patient.
- These results demonstrate that BCR-ABL translocation breakpoints can occur within coding exons.
Implications:
- This discovery expands the understanding of BCR-ABL fusion mechanisms in leukemia.
- It suggests potential for novel diagnostic markers or therapeutic targets based on these aberrant fusion sites.
- Further research into non-consensus splice site involvement in translocations is warranted.